SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-049136
Filing Date
2024-02-28
Accepted
2024-02-28 07:10:00
Documents
14
Period of Report
2024-02-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d757603d8k.htm   iXBRL 8-K 33537
  Complete submission text file 0001193125-24-049136.txt   162048

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20240222.xsd EX-101.SCH 2871
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20240222_lab.xml EX-101.LAB 18757
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20240222_pre.xml EX-101.PRE 11724
15 EXTRACTED XBRL INSTANCE DOCUMENT d757603d8k_htm.xml XML 3802
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 24690149
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)